Moreover, higher LINC02470 expression was associated with worse overall survival of bladder cancer patients in the GSE13507 dataset; LINC02470 conferred a 2.156-fold higher risk (95% CI 1.256–3.700, p = 0.004, log-rank test) of bladder cancer-related death (Figure 1C). Here, LINC02470 is linked to urinary bladder cancer.